These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8988765)

  • 1. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
    Johnson DM; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):53-7. PubMed ID: 8988765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
    Goldstein FW; Kitzis MD; Acar JF
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2218-20. PubMed ID: 7811053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
    Shonekan D; Handwerger S; Mildvan D
    J Antimicrob Chemother; 1997 Mar; 39(3):405-9. PubMed ID: 9096191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in tetracycline antibiotics.
    Sum PE; Sum FW; Projan SJ
    Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
    Brown BA; Wallace RJ; Onyi G
    Antimicrob Agents Chemother; 1996 Apr; 40(4):874-8. PubMed ID: 8849243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Finegold SM
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2513-5. PubMed ID: 7840601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of two glycylcyclines against gram-positive bacteria.
    Eliopoulos GM; Wennersten CB; Cole G; Moellering RC
    Antimicrob Agents Chemother; 1994 Mar; 38(3):534-41. PubMed ID: 8203851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.
    Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):19-36. PubMed ID: 10744364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of two glycylcyclines.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1994 May; 38(5):1096-102. PubMed ID: 8067744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.
    Weiss WJ; Jacobus NV; Petersen PJ; Testa RT
    J Antimicrob Chemother; 1995 Jul; 36(1):225-30. PubMed ID: 8537270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
    Sum PE; Petersen P
    Bioorg Med Chem Lett; 1999 May; 9(10):1459-62. PubMed ID: 10360756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):784-6. PubMed ID: 7802861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of two glycylcyclines against enterococci resistant to other agents.
    Fraise AP; Brenwald N; Andrews JM; Wise R
    J Antimicrob Chemother; 1995 Jun; 35(6):877-81. PubMed ID: 7559199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
    Jamjian C; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines.
    Whittington WL; Roberts MC; Hale J; Holmes KK
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1864-5. PubMed ID: 7486935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.
    Projan SJ
    Pharmacotherapy; 2000 Sep; 20(9 Pt 2):219S-223S; discussion 224S-228S. PubMed ID: 11001329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.